DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137,742,391 | +1.2% | 555,189 | -10.3% | 0.28% | +2.5% |
| Q2 2023 | $136,173,492 | -28.8% | 619,022 | -24.9% | 0.28% | -32.3% |
| Q1 2023 | $191,173,888 | +75958.5% | 824,079 | -13.0% | 0.41% | -15.1% |
| Q4 2022 | $251,351 | -99.8% | 946,995 | +125.4% | 0.48% | +67.1% |
| Q3 2022 | $110,767,000 | -15.6% | 420,122 | -22.4% | 0.29% | -7.1% |
| Q2 2022 | $131,248,000 | -16.8% | 541,233 | -9.6% | 0.31% | +3.4% |
| Q1 2022 | $157,802,000 | -21.7% | 598,569 | -14.0% | 0.30% | -12.9% |
| Q4 2021 | $201,438,000 | +16.0% | 696,255 | +5.3% | 0.34% | +10.7% |
| Q3 2021 | $173,712,000 | +12.4% | 661,291 | -3.2% | 0.31% | +17.5% |
| Q2 2021 | $154,601,000 | +16.6% | 683,191 | -1.3% | 0.26% | +16.4% |
| Q1 2021 | $132,619,000 | -22.5% | 692,497 | -26.6% | 0.23% | -19.0% |
| Q4 2020 | $171,187,000 | +25.8% | 942,898 | +27.3% | 0.28% | +18.7% |
| Q3 2020 | $136,041,000 | +18.2% | 740,854 | +1.4% | 0.24% | +11.9% |
| Q2 2020 | $115,076,000 | -35.8% | 730,915 | -43.6% | 0.21% | +18.6% |
| Q1 2020 | $179,282,000 | +519.9% | 1,295,290 | +512.4% | 0.18% | +276.6% |
| Q4 2019 | $28,919,000 | +14.3% | 211,502 | +10.7% | 0.05% | +11.9% |
| Q3 2019 | $25,304,000 | +3.1% | 191,002 | -2.3% | 0.04% | 0.0% |
| Q2 2019 | $24,541,000 | +46.0% | 195,547 | +36.8% | 0.04% | +35.5% |
| Q1 2019 | $16,807,000 | -54.1% | 142,947 | -64.8% | 0.03% | -16.2% |
| Q4 2018 | $36,594,000 | +75.8% | 405,660 | +82.3% | 0.04% | +2.8% |
| Q3 2018 | $20,818,000 | +10.7% | 222,530 | 0.0% | 0.04% | +2.9% |
| Q2 2018 | $18,808,000 | -1.9% | 222,530 | -7.6% | 0.04% | -5.4% |
| Q1 2018 | $19,165,000 | -48.5% | 240,730 | -50.0% | 0.04% | +8.8% |
| Q4 2017 | $37,248,000 | +81.7% | 481,860 | +101.6% | 0.03% | 0.0% |
| Q3 2017 | $20,498,000 | -63.9% | 238,962 | -64.5% | 0.03% | -67.0% |
| Q2 2017 | $56,758,000 | -39.0% | 672,562 | -38.2% | 0.10% | -39.8% |
| Q1 2017 | $93,042,000 | +30.9% | 1,087,833 | +13.0% | 0.17% | +27.6% |
| Q4 2016 | $71,062,000 | +17.8% | 962,911 | +25.1% | 0.13% | +26.4% |
| Q3 2016 | $60,314,000 | -0.5% | 769,411 | +28.2% | 0.11% | -7.0% |
| Q2 2016 | $60,604,000 | +16.5% | 600,039 | +9.4% | 0.11% | +5.6% |
| Q1 2016 | $52,015,000 | -99.9% | 548,339 | -33.1% | 0.11% | -38.3% |
| Q4 2015 | $76,109,494,000 | +87171.5% | 819,439 | -19.9% | 0.18% | -12.5% |
| Q3 2015 | $87,210,000 | -4.5% | 1,023,475 | -4.1% | 0.20% | +9.3% |
| Q2 2015 | $91,345,000 | -13.4% | 1,067,241 | -14.1% | 0.18% | -16.1% |
| Q1 2015 | $105,497,000 | +7.9% | 1,242,603 | +8.9% | 0.22% | +16.6% |
| Q4 2014 | $97,801,000 | +29.6% | 1,141,065 | +14.9% | 0.19% | +22.2% |
| Q3 2014 | $75,445,000 | +6.2% | 992,960 | +10.1% | 0.15% | +0.7% |
| Q2 2014 | $71,032,000 | +51.0% | 902,223 | +43.8% | 0.15% | +23.6% |
| Q1 2014 | $47,049,000 | -51.4% | 627,321 | -50.0% | 0.12% | -14.0% |
| Q4 2013 | $96,858,000 | +117.4% | 1,254,642 | +95.2% | 0.14% | +1.4% |
| Q3 2013 | $44,550,000 | -5.4% | 642,672 | -13.6% | 0.14% | -4.1% |
| Q2 2013 | $47,087,000 | – | 743,870 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |